Back to Search

TINA STAMEY, CD (DONA)

CD (DONA)

Doula

NPI: 1649541780Individual

Specialties, Licenses & Credentials

DoulaPrimary

Doula

Code: 374J00000X

Research & Publications (20)

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
PMID 17437806·J Urol·2007
4-observational
Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
PMID 16112424·Cancer Lett·2005
4-observational
The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
PMID 15541106·BJU Int·2004
8-other
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.
PMID 15383627·Mol Cancer Res·2004
8-other
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
PMID 15371827·J Urol·2004
4-observational
Elevated expression of inhibin alpha in prostate cancer.
PMID 14665874·J Urol·2004
8-other
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
PMID 14665355·Urology·2003
4-observational
Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue?
PMID 14634393·J Urol·2003
8-other
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
PMID 14532777·J Urol·2003
3-trial
Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.
PMID 12853799·J Urol·2003
8-other
More information on prostate specific antigen and prostate cancer.
PMID 12853798·J Urol·2003
8-other
Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
PMID 12629351·J Urol·2003
8-other
Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
PMID 12540499·Cancer Epidemiol Biomarkers Prev·2003
8-other
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
PMID 12384161·Urology·2002
4-observational
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
PMID 12384160·Urology·2002
4-observational
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
PMID 12384157·Urology·2002
4-observational
Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
PMID 12210487·Prostate·2002
8-other
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens.
PMID 12137824·Urology·2002
8-other
Re: Pathologic features of prostate cancer found at population-based screening with a four-year interval.
PMID 11830613·J Natl Cancer Inst·2002
8-other
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
PMID 11743285·J Urol·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
105 LYNDON PORTER PL
CUMMING, GA 30040

Location

Practice Location

105 LYNDON PORTER PL, CUMMING, GA
(678) 923-6436

Quick Facts

NPI
1649541780
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile